Eligo Bioscience raises $20 million to target the microbiome more precisely

 French startup Eligo Bioscience just raised $20 million to develop next-gen biotherapeutics. Khosla Ventures is leading the round. This is also Khosla Ventures’ first investment in a French startup. Existing investor Seventure Partners is also participating, and the startup received a $2 million grant from the Worldwide Innovation Challenge. Eligo Bioscience has been working on a new way… Read More

from iFeeltech IT News Mix4 https://techcrunch.com/2017/09/26/eligo-bioscience-raises-20-million-to-target-the-microbiome-more-precisely/?ncid=rss

from
https://ifeeltechinc.wordpress.com/2017/09/26/eligo-bioscience-raises-20-million-to-target-the-microbiome-more-precisely/